Sai Life Sciences, Centrix Pharma Solutions and Agility Life Sciences recently came together to host a webinar bringing together industry […]
High-Throughput Experimentation platform goes live in Hyderabad
28 Apr 2026
The High Throughput Experimentation (HTE) platform is now operational at our Integrated R&D Campus in Hyderabad, India. The system integrates automated experimental execution with structured data capture to support reproducible, high-quality screening and full traceability of results.
Designed to evaluate multiple variables within a single experimental matrix, the platform enables rapid assessment of chemical space during route scouting, optimization, and troubleshooting activities. This supports data-driven route selection and reduces uncertainty prior to scale-up.
Reactions are conducted at microscale, minimizing material consumption while enabling broad condition screening. The capability extends beyond catalytic chemistry and includes diverse reaction classes such as biocatalysis, with further expansion planned.
HTE is particularly effective for screening categorical variables and selecting reagents in a structured and data-driven manner. Screening outputs are generated with downstream process development in mind, ensuring translation into scalable workflows rather than remaining isolated exploratory data.
The platform is intended to accelerate decision-making, improve experimental consistency, and enhance confidence in process development strategies across programs.
Related News
Revenue up by 43%; EBITDA up by 79%; Net Profit up by 199% Hyderabad, February 05, 2026: Sai Life Sciences […]
6 Feb 2026
Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract Research, […]